These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15035165)

  • 1. [Fracture Intervention Trial I and II(alendronate)].
    Nakamura T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():427-32. PubMed ID: 15035165
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of alendronate therapy on osteoporotic fracture in the vertebral fracture arm of the Fracture Intervention Trial.
    Black DM; Thompson DE
    Int J Clin Pract Suppl; 1999 Apr; 101():46-50. PubMed ID: 12669740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current research in adequate treatment by Osteoporosis Research Group].
    Orimo H; Miyakawa N; Kuroda T
    Clin Calcium; 2006 Sep; 16(9):1500-7. PubMed ID: 16951475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of osteoporosis combined with a bisphosphonate and vitamin D3].
    Kobayashi S; Shiraki M; Takaoka K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():461-5. PubMed ID: 15035171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
    Soen S
    Nihon Rinsho; 2009 May; 67(5):985-90. PubMed ID: 19432121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate and vertebral fracture risk.
    Seeman E
    Mayo Clin Proc; 2005 Sep; 80(9):1236, 1238; author reply 1238, 1240. PubMed ID: 16178508
    [No Abstract]   [Full Text] [Related]  

  • 7. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD
    Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alendronate].
    Okazaki R
    Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [FOSAVANCE -- alendronate plus vitamin D in a weekly tablet].
    Praxis (Bern 1994); 2006 Jul; 95(27-28):2 p following 1084. PubMed ID: 16888927
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].
    Nakamura T
    Nihon Rinsho; 2009 May; 67(5):903-8. PubMed ID: 19432107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing osteoporotic fractures with alendronate.
    Maughan KL
    J Fam Pract; 1997 Apr; 44(4):336. PubMed ID: 9148031
    [No Abstract]   [Full Text] [Related]  

  • 13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].
    Soen S
    Clin Calcium; 2011 Jan; 21(1):116-9. PubMed ID: 21187604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
    Hochberg MC; Thompson DE; Black DM; Quandt SA; Cauley J; Geusens P; Ross PD; Baran D;
    J Bone Miner Res; 2005 Jun; 20(6):971-6. PubMed ID: 15883637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate].
    Kishimoto H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():365-8. PubMed ID: 18161133
    [No Abstract]   [Full Text] [Related]  

  • 19. [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].
    Adachi JD
    MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529719
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vertebroplasty for pain reduction in osteoporotic vertebral fracture: possibly only a placebo effect?].
    Weber MA
    Radiologe; 2010 Apr; 50(4):325-6. PubMed ID: 20157690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.